Build Your Company with RA Capital

Artist: Luke Jerram | Title: Coronavirus

Why Work with Us?

RA Capital is interested in finding, funding, and building companies that develop important innovations in human health. Our company-building efforts are guided by our internal research division known as TechAtlas, our dedicated Venture Team led by seasoned Managing Directors, and the experienced entrepreneurs in our internal incubator.

Get in touch with us today

Whether you have an idea in search of an application, a strategy based on validated targets, or a novel platform, device, or diagnostic, we want to hear from you. Together we can map out what your next move should be.

How We Can Help

As a driven and creative researcher, entrepreneur, or executive, your most important asset is your time. Of all the problems you can solve with your idea or technology, which will have the most impact and create the most value? Which problems are worthy of your time? The RA Capital Venture Team is here to help you take into account the time, complexity, competition, and capital required for each possible approach and guide you toward the best decision. Our team of experienced company creators and drug developers has launched dozens of companies and can put our expertise and resources at your disposal – including our internal research division, TechAtlas, which provides encyclopedic knowledge of the biopharmaceutical industry.

If it makes sense to launch and build a company, we can help with or take the lead on financing, technology transfer, incubation, strategy, and hiring to help you achieve your vision.

Academics:
If you work in academia or non-profit research and want to see your discoveries make a difference for patients, we have extensive experience in collaborating with and spinning technology out of academia. If you want to start a company but also keep your academic career, we can work with you through a variety of academic founder models that will keep you centrally involved in the progress of your discoveries, ranging from research sponsorship to equity and involvement with the Scientific Advisory Board and/or Board of Directors.

Entrepreneurs:
If you are seeking a home for your ideas, we bring focus, resources, and tools to accelerate your plan from the earliest stages through IPO, corporate partnerships, and beyond.

Executives and Scientific Leaders:
If you are interested in applying your skills to something new, we are always recruiting great people to our growing companies and would like to help you find a position that matches your skills and interests.

Crossover/Venture Investments

Information listed is as of April 01, 2020. The Crossover/Venture Investments tab reflects private companies that currently are in RA Capital’s portfolio in an open side pocket. If a company becomes public or is acquired by a third-party acquirer, it instead will be reflected under the Investments Acquired/IPO’d tab above. If a company is dissolved or redeems RA Capital’s investment, or another investor in a company purchases RA Capital‘s investment, such company will be removed from this website.

Notwithstanding the foregoing, certain private companies are not illustrated (1) because of confidentiality restrictions or arrangements or (2) because, to the best of RA Capital’s knowledge, such company does not have a logo or active website. References, either general or specific, to securities and/or issuers are for illustrative purposes only and are not intended to be, and should not be interpreted as, recommendations to purchase or sell such securities. The earliest illustrated Crossover/Venture Investment occurred in February 2012. RA Capital makes no representations, and it should not be assumed, that past investment selection is necessarily indicative of future investment selection or performance.

“Working with RA Capital has been a transformative experience for Imbria...”

DA GROS
CEO OF IMBRIA PHARMACEUTICALS